Lipid metabolism and disordersDiabetes, Cardiovascular Risks, and LipoproteinsDiabetes and associated disorders

*Real-World Experience with ApoC-III Inhibition in Patients with Persistent Chylomicronemia

Kamil Winnicki, Nataliya Pyslar

2026.6.1Journal of Clinical Lipidology

DOI: 10.1016/j.jacl.2026.05.166

Abstract

Abstract is not available.

Citation format

WINNICKI, Kamil; PYSLAR, Nataliya. *Real-world experience with apoc-iii inhibition in patients with persistent chylomicronemia. Journal of Clinical Lipidology, 2026, 20(6): e109.